As Anti-CCP is the most prominent RA diagnostic and prognosis marker [10,13], we confirmed that the patient group with higher VEGF values also had a statistically higher number of anti-CCP positive patients. The gene discussed is VEGFA; the disease is rheumatoid arthritis.